n.粘连形成；结缔织生成

Desmoplasia is a characteristic feature of fibrotic diseases, such as cancer.
描述性增生是纤维化疾病的特征，如癌症。
Pathologists observed desmoplasia in the surrounding tissue of the tumor.
病理学家在肿瘤周围组织中观察到了描述性增生。
Treatment for desmoplasia often involves addressing the underlying cause, like inflammation or hormonal imbalances.
治疗描述性增生通常需要解决根本原因，如炎症或激素失衡。
In breast cancer, aggressive desmoplasia can hinder chemotherapy effectiveness.
在乳腺癌中，强烈的描述性增生可能会影响化疗的效果。
The surgical removal of desmoplastic tissue during surgery can be challenging for surgeons.
手术期间移除描述性增生组织对外科医生来说是一项挑战。
Desmoplasia can lead to reduced blood flow and oxygen supply to affected organs.
描述性增生可能导致受影响器官血流和氧气供应减少。
Researchers studying desmoplasia are exploring new drugs that target the excessive collagen production.
研究描述性增生的研究人员正在探索针对过度胶原蛋白生产的新型药物。
Some patients with desmoplasia experience pain due to the tight, fibrous tissue it creates.
一些患有描述性增生的患者因其产生的紧致纤维组织而感到疼痛。
Early detection and treatment of desmoplasia can improve outcomes for patients with certain types of cancer.
早期发现并治疗描述性增生可以改善某些类型癌症患者的预后。
A combination therapy targeting both the cancer cells and desmoplasia is being investigated as a potential breakthrough.
一种针对癌细胞和描述性增生的联合疗法正在被调查，作为可能的突破。